Medulloblastoma Clinical Trials

Recruiting Trials - Current as of: 2019-11-12

54 clinical trials are currently available across 8 different countries:

Clinical Trial
Sponsor
Country
United States of America
United States of AmericaNational Cancer Institute (NCI)

Volitinib in Treating Participants With Recurrent or Refractory Primary CNS Tumors
Last Updated: 2019-11-07
Originally Posted: 2018-07-24

United States of America
United States of AmericaWashington University School of Medicine

Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
Last Updated: 2019-11-05
Originally Posted: 2012-07-30

Canada
CanadaNational Cancer Institute (NCI)
United States of America
United States of AmericaIstari Oncology, Inc.

Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Last Updated: 2019-10-24
Originally Posted: 2017-02-02

United States of America
United States of AmericaAugusta University
United States of America
United States of AmericaDana-Farber Cancer Institute
United States of America
United States of AmericaUniversity of California, San Francisco

Fimepinostat in Treating Brain Tumors in Children and Young Adults
Last Updated: 2019-10-07
Originally Posted: 2019-03-26

United States of America
United States of AmericaSeattle Children's Hospital
United States of America
United States of AmericaPediatric Brain Tumor Consortium
United States of America
United States of AmericaPediatric Brain Tumor Consortium

Phase I Study of APX005M in Pediatric CNS Tumors
Last Updated: 2019-09-23
Originally Posted: 2017-12-15

United States of America
United States of AmericaPediatric Brain Tumor Consortium
United States of America
United States of AmericaSt. Jude Children's Research Hospital

Study of Stored Tumor Samples in Young Patients With Brain Tumors
Last Updated: 2019-09-20
Originally Posted: 2009-05-09

United States of America
United States of AmericaUniversity of Alabama at Birmingham

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Last Updated: 2019-09-12
Originally Posted: 2019-04-09

United States of America
United States of AmericaWeill Medical College of Cornell University
United States of America
United States of AmericaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Austria
AustriaMedical University of Vienna
United States of America
United States of AmericaUniversity of California, San Francisco
United States of America
United States of AmericaNational Institutes of Health Clinical Center (CC)

Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers
Last Updated: 2019-06-29
Originally Posted: 2017-05-31

United States of America
United States of AmericaThe University of Texas Health Science Center, Houston
United States of America
United States of AmericaUniversity of Iowa
United States of America
United States of AmericaSt. Jude Children's Research Hospital

Methionine PET/CT Studies In Patients With Cancer
Last Updated: 2019-06-17
Originally Posted: 2009-02-09

United States of America
United States of AmericaNational Institutes of Health Clinical Center (CC)

Rare CNS Tumors Outcomes &Risk
Last Updated: 2019-06-12
Originally Posted: 2017-08-15

United States of America
United States of AmericaSeattle Children's Hospital
Australia
AustraliaSt. Jude Children's Research Hospital

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
Last Updated: 2019-06-07
Originally Posted: 2013-06-10

United States of America
United States of AmericaDuke University

PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
Last Updated: 2019-05-30
Originally Posted: 2017-09-27

United States of America
United States of AmericaOncurious NV
Canada
CanadaNationwide Children's Hospital
United States of America
United States of AmericaNicklaus Children's Hospital f/k/a Miami Children's Hospital
China
ChinaGuangdong Zhongsheng Pharmaceutical Co., Ltd.

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors
Last Updated: 2019-02-18
Originally Posted: 2018-11-05

United States of America
United States of AmericaMasonic Cancer Center, University of Minnesota

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Last Updated: 2019-02-11
Originally Posted: 2012-01-04

United States of America
United States of AmericaSt. Jude Children's Research Hospital

Components of Social Functioning in Survivors of Pediatric Brain Tumors
Last Updated: 2019-01-17
Originally Posted: 2017-11-28

Canada
CanadaBritish Columbia Cancer Agency

DOTATOC PET/CT for Imaging NET Patients
Last Updated: 2018-12-21
Originally Posted: 2018-06-08

China
ChinaXinhua Hospital, Shanghai Jiao Tong University School of Medicine

Study of Tomotherapy HD in Medulloblastoma
Last Updated: 2018-09-16
Originally Posted: 2018-09-16

France
FranceCentral Hospital, Nancy, France
Germany
GermanyUniversitätsklinikum Hamburg-Eppendorf

International HIT-MED Registry (I-HIT-MED)
Last Updated: 2017-10-17
Originally Posted: 2015-02-04

Austria
AustriaUniversitätsklinikum Hamburg-Eppendorf

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Last Updated: 2017-05-05
Originally Posted: 2014-02-07

France
FranceGustave Roussy, Cancer Campus, Grand Paris

* indicates the trial status in ongoing and not necessarily recruiting. See trial link for details.